Skip to main content
Premium Trial:

Request an Annual Quote

Resolve Biosciences, Zeiss Partner to Enhance Spatial Biology Imaging Tech

NEW YORK — Spatial biology startup Resolve Biosciences has partnered with optics firm Zeiss on the development of new microscopy and 3D imaging technologies, the German companies said on Tuesday.

Resolve, which was founded by former Qiagen executives and emerged from stealth mode in late 2020 following a $24 million Series A round, has developed a spatial biology analysis platform — dubbed Molecular Cartography — for viewing transcriptome activity at subcellular resolution. The platform includes Zeiss microscopy technology and is slated for commercial launch later this year.

Under the terms of their collaboration, Zeiss, headquartered in Jena, and Resolve, based in Monheim am Rhein, will develop new optical systems and computational approaches to enhance the Molecular Cartography workflow. Resolve said that it aims to eventually add DNA, protein, and metabolomic data layers to the technology.

Financial and other terms of the agreement were not disclosed.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.